Su1733 ORAL IL-23R ANTAGONIST MINIPROTEIN MB1 IS AS EFFECTIVE AS GUSELKUMAB IN A PRECLINICAL MODEL OF COLITIS
Year: 2024
Type: conference-abstract
Source: Gastroenterology
Authors: Stephanie Berger, Franziska Seeger, Ta-Yi Yu, Merve Aydin, Caleb Glassman, Lauren Arguinchona, Catherine Sniezek, Alyssa Blackstone, Lauren Carter, Rashmi Ravichandran, Maggie Ahlrichs, Michael P. Murphy, Ingrid S. Pultz, Alex Kang, Asim Bera, Lance Stewart, K. Christopher Garcia, Florian Beigel, Matthias Siebeck, Roswitha Gropp, David Baker
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4396643936